Carisma Therapeutics Inc - Netong Asset Bawat Isang Bahagi CARM
Nagsisikap ang Carisma Therapeutics (CARM) para sa pandaigdigang pamumuno sa terapiya ng solid tumor sa pamamagitan ng CAR-macrophages. Ang book value bawat siyer ay nagpapakita ng pag-unlad tungo sa layuning ito, kung saan ang -1.10 ay nagpapakita ng kasalukuyang volume ng metric. Gayunpaman, ang pag-unlad ay nahahadlangan ng mga komplikasyon sa automation ng cell culture at ang pangangailangan para sa mahigpit na kontrol sa express delivery ng mga biomaterials, na lumilikha ng ilang mga operational barrier.
%20Accounting%20Book%20Value%20Bawat%20Bahagi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CARM_-_Carisma-Therapeutics_-_Accounting-Value-per-Share "CARM (Carisma Therapeutics Inc) kasaysayan ng Netong Asset Bawat Isang Bahagi mula 28.04.2023 hanggang 25.10.2025 | 👁️GURU.Markets👁️")
Carisma Therapeutics Inc - mga analytical breakdown at pangunahing sukatan (CARM)
- presyo at pagtataya ng pinagkasunduang presyo:
- datos sa market capitalization:
- datos sa book capitalization:
- datos sa utang at liquidity:
Kabuuang Utang sa Kapital Carisma Therapeutics|CARM - Pangmatagalang utang sa kapital|Panandaliang utang sa equity Carisma Tx|CARM - Mga pinagsamang obligasyon sa utang|Ratio ng utang sa book capitalization Carisma Therapeutics Inc.|CARM - Mga pangmatagalang pananagutan ng kumpanya|Mga panandaliang utang ng kumpanya Carisma Therapeutics
Fundamental valuation ng kumpanya:carismatx.com - CARM
Ang book value per share ay sumasalamin sa bahagi ng equity na nauugnay sa isang solong security, na nagpapahintulot sa mga mamumuhunan na tasahin ang aktwal na halaga ng net assets nang hiwalay sa espekulasyon ng merkado. Sa pamamagitan ng pagsusuri sa historical trend ng book value per share, maaaring matukoy kung ang kapital ng Carisma Therapeutics (CARM) ay nababawasan habang isinasagawa ang magastos na scaling ng CAR-M platform at ang ekspansyon nito sa solid tumor therapy segment.
Mga kakumpitensya ng Carisma Therapeutics (CARM)
Netong Asset Bawat Isang Bahagi Argenx (ARGX)|BNTX: Accounting Value ng Bahagi|ABVX (Abivax Corp) - Netong Asset Bawat Isang Bahagi|ADMA (admabiologics.com) - Accounting Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Protagonist PTGX|Book Value ng Bahagi Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value Bawat Bahagi|Accounting Value ng Bahagi Grifols Biemat (GRFS)|Book Value Bawat Bahagi ADPT (Adaptive Biotechnologies)|celldex.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value ng Bahagi|VERA (Vera Pharma) - Netong Asset Bawat Isang Bahagi|Dianthus Corp (DNTH) - Accounting Book Value Bawat Bahagi|PHVS (Pharvaris N.V.) - Book Value Bawat Bahagi|Book Value Bawat Bahagi AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Book Value Bawat Bahagi|Accounting Value ng Bahagi Precigen Inc (PGEN)|Book Value Bawat Bahagi PHAR|Nektar Corp - Net Assets Bawat Bahagi|UPB: Netong Asset Bawat Isang Bahagi|ZBIO: Accounting Book Value Bawat Bahagi|IMNM (Immunome) - Netong Asset Bawat Isang Bahagi|Accounting Book Value Bawat Bahagi Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Book Value Bawat Bahagi|Book Value Bawat Bahagi SEPN|Netong Asset Bawat Isang Bahagi Pieris Pharmaceuticals PVLA|Stockholders Equity Bawat Bahagi savarapharma.com (SVRA)|RIGL: Book Value Bawat Bahagi|Net Asset Value Bawat Bahagi AnaptysBio Inc ANAB|ATXS: Book Value Bawat Bahagi|ENGN - Accounting Book Value Bawat Bahagi|RAPT: Book Value Bawat Bahagi|JBIO (Aerovate Therapeutics) - Book Value Bawat Bahagi|ACRS - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - Book Value Bawat Bahagi|Net Assets Bawat Bahagi CABA (Cabaletta Bio Inc)|Netong Asset Bawat Isang Bahagi VTYX|theratech.com - Net Assets Bawat Bahagi|AVTX: Netong Asset Bawat Isang Bahagi|ELDN - Accounting Book Value Bawat Bahagi|AGEN: Book Value Bawat Bahagi|Book Value Bawat Bahagi Climb Bio, Inc|ZURA - Accounting Book Value Bawat Bahagi|Accounting Value ng Bahagi atyrpharma.com (ATYR)|Accounting Book Value Bawat Bahagi Adagene|Book Price ng Bahagi ikenaoncology.com (IMA)|Book Value Bawat Bahagi Shattuck Labs|Accounting Value ng Bahagi Equillium Inc EQ|CNTB (Connect Pharma) - Book Value Bawat Bahagi|IMUX: Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi atarabio.com ATRA|InflaRx (IFRX) - Accounting Value ng Bahagi|XFOR (X4 Pharma) - Book Value Bawat Bahagi|Book Value Bawat Bahagi ACET|CELU - Netong Asset Bawat Isang Bahagi|Book Value ng Bahagi inmunebio.com (INMB)|BRNS: Book Value Bawat Bahagi|KZR - Net Asset Value Bawat Bahagi|SAB Biotherapeutics, Inc - Accounting Book Value Bawat Bahagi|Akari Therapeutics, Plc (AKTX) - Book Value Bawat Bahagi|ENLV - Accounting Book Value Bawat Bahagi|Q32 Bio (QTTB) - Book Price ng Bahagi|GOVX: Book Value Bawat Bahagi|Net Assets Bawat Bahagi Edesa Biotech Inc|Book Value Bawat Bahagi IBIO (iBio Corp)|Accounting Book Value Bawat Bahagi XTLB (XTL Bio)|Netong Asset Bawat Isang Bahagi BOLT|Net Assets Bawat Bahagi HCW Biologics, Inc. HCWB|APVO: Book Value Bawat Bahagi|AIM - Accounting Book Value Bawat Bahagi|ADTX: Book Value Bawat Bahagi|GRI (GRI Bio Corporation) - Book Value Bawat Bahagi|XRTX - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi HIND|Netong Asset Bawat Isang Bahagi REVB (Revelation Biosciences, Inc.)|Accounting Book Value Bawat Bahagi INDP (Indaptus Therapeutics Inc)|Scinai (SCNI) - Netong Asset Bawat Isang Bahagi|Book Value ng Bahagi CalciMedica Inc CALI|Book Value Bawat Bahagi Affimed Therapeutics (AFMD)|ALLK - Accounting Value ng Bahagi|HOOK: Book Value Bawat Bahagi|IGMS (IGM Biosciences) - Book Value Bawat Bahagi|ITOS - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi OCEA|Netong Asset Bawat Isang Bahagi TCBP (TC Biopharm)|Accounting Book Value Bawat Bahagi thirdharmonicbio.com (THRD)